Atherosclerotic plaque rupture - Pathologic basis of plaque stability and instability

Cardiovascular Research

Volumn 41, Issue 2, 1999, Pages 334-344

  Van Der Wal, Allard C ^a   Becker, Anton E ^a  

^a ACADEMIC MEDICAL CENTER   (Netherlands)

Author keywords

Acute coronary syndromes; Atherosclerosis; Human; Macrophages; Pathology; Plaque rupture; Smooth muscle cells

Indexed keywords

ACUTE HEART INFARCTION; ANGINA PECTORIS; APOPTOSIS; ATHERECTOMY; ATHEROSCLEROSIS; ATHEROSCLEROTIC PLAQUE; CORONARY ARTERY OBSTRUCTION; CORONARY ARTERY THROMBOSIS; HEART MUSCLE ISCHEMIA; HISTOPATHOLOGY; HUMAN; INFLAMMATORY CELL; MACROPHAGE; NEOVASCULARIZATION (PATHOLOGY); PATHOPHYSIOLOGY; PRIORITY JOURNAL; REVIEW; SMOOTH MUSCLE FIBER; THROMBOGENESIS; UNSTABLE ANGINA PECTORIS;

ACUTE DISEASE; ADULT; CORONARY ARTERIOSCLEROSIS; CORONARY THROMBOSIS; CORONARY VESSELS; FEMALE; HUMANS; INFLAMMATION MEDIATORS; LIPID METABOLISM; MACROPHAGES; MALE; MIDDLE AGED; T-LYMPHOCYTES;

EID: 0033054037     PISSN: 00086363     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0008-6363(98)00276-4     Document Type: Review

References (85)

1. Ross R. The pathogenesis of atherosclerosis: a perspective for the 1990s. Nature. 362:1993;801-809.
2. Davies M.J., Thomas A.C. Plaque fissuring the cause of acute myocardial infarction, sudden ischemic death and crescendo angina. Br Heart J. 53:1985;363-373.
3. Falk E. Morphologic features of unstable atherothrombotic plaques underlying acute coronary syndromes. Am J Cardiol. 63(suppl E):1989;114E-120E.
4. Eliasziv M., Streifler J.Y., Fox A.L.et al. Significance of plaque ulceration in symptomatic patients with high grade carotid stenosis. Stroke. 25:1994;304-308.
5. Davies M.J. A macro and microview of coronary vascular insult in ischemic heart disease. Circulation. 82(suppl II):1990;II38-II46.
6. Fuster V, Badimon L, Badimon JJ, Chesebro JH. The pathogenesis of coronary artery disease and the acute coronary syndromes. N Engl J Med 1992;26:242-250; 310-318.
7. Zarins CK, Xu C, Glagov S. Clinical correlations of atherosclerosis. aortic disease. In: Fuster V, editor. Syndromes of atherosclerosis: correlations of clinical imaging and pathology. Armonk, NY: Futura Publishing Company, Inc. 1996, pp. 33-42.
8. Davies M.J. Stability and instability: two faces of coronary atherosclerosis. Circulation. 94:1996;2013-2020.
9. Steinberg D., Witztum J.L. Lipoproteins and atherogenesis: current concepts. J Am Med Assoc. 264:1990;3047-3052.
10. Wight T.N. Cell biology of arterial proteoglycans. Arteriosclerosis. 9:1989;1-20.
11. Ball R.Y., Stowers E.C., Burton J.H.et al. Evidence that the death of macrophage foam cells contributes to the lipid core of atheroma. Atherosclerosis. 114:1995;45-54.
12. Davies M.J., Richardson P., Woolf N., Katz D., Mann J. Risk of thrombosis in human atherosclerotic plaque: role of extracellular lipid, macrophages and smooth muscle cell content. Br Heart J. 69:1993;377-381.
13. van der Wal A.C., Becker A.E., Tigges A.J., van der Loos C.M., Das P.K. Fibrous and lipid-rich plaques atherosclerotic plaques are part of interchangeable morphologies related to inflammation B. A concept. Coron Artery Dis. 5:1994;463-469.
14. Richardson P.D., Davies M.J., Born G.V.R. Influence of plaque configuration and stress distribution on fissuring of coronary atherosclerotic plaques. Lancet. 2:1989;941-944.
15. Falk E. Why do plaques rupture? Circulation. 86(suppl III):1992;III30-III42.
16. Rosenschein U., Ellis S.G., Haudenschild C.C.et al. Comparing of histopatologic features of coronary lesions obtained from directional atherectomy in stable versus acute coronary syndromes. Am J Cardiol. 73:1994;508-510.
17. Arbustini E., De Servi S., Bramucci E.et al. Comparison of coronary lesions obtained by directional atherectomy in unstable angina, stable angina and restenosis after either atherectomy or angioplasty. Am J Cardiol. 75:1995;675-682.
18. van der Wal A.C., Becker A.E.et al. Clinically stable angina is not necessarily associated with histologically stable atherosclerotic plaques. Heart. 76:1996;112-117.
19. Hangartner J.R.W., Charlston A.J., Davies M.J.et al. Morphological characteristics of clinically significant coronary artery stenosis in stable angina. Br Heart J. 56:1986;501-508.
20. van der Wal A.C., Becker A.E., van der Loos C.M., Das P.K. Site of intimal rupture or erosion of thrombosed coronary atherosclerotic plaques is characterized by an inflammatory process irrespective of the dominant plaque morphology. Circulation. 89:1994;36-44.
21. Cheng G.C., Loree H.M., Kamm R.D., Fishbein M.C., Lee R.T. Distribution of circumferential stress in ruptured and stable atherosclerotic lesions: a structural analysis with histopathologic correlation. Circulation. 87:1993;1179-1187.
22. Lendon C.L., Davies N.J., Born G.V.R., Richardson P.D. Atherosclerotic plaques are locally weakened when macrophage density is increased. Atherosclerosis. 87:1991;87-90.
23. Munro J.M., Cotran R.S. The pathogenesis of atherosclerosis. Atherogenesis and inflammation. Lab Invest. 58:1988;249-261.
24. Jonasson L., Holm J., Skalli O., Bondjer G., Hansson G.K. Regional accumulation of T-cells macrophages and smooth muscle cells in the human atherosclerotic plaque. Atherosclerosis. 6:1986;131-138.
25. Gown A.M., Tsukada T., Ross R. Human atherosclerosis. II. Immunocytochemical analysis of the cellular composition of human atherosclerotic lesions. Am J Pathol. 125:1986;191-207.
26. van der Wal A.C., Das P.K., Bentz van de Berg D.B., van der Loos C.M., Becker A.E. Atherosclerotic lesions in humans. In situ immunophenotypic analysis suggesting an immune mediated response. Lab Invest. 61:1989;166-170.
27. Kaartinen M., Pentilla A., Kovanen P. Accumulation of activated mast cells in the shoulder region of human coronary atheroma, the predilection site of atheromatous rupture. Circulation. 90:1994;1669-1678.
28. O'Brien K.D., McDonald T.O., Chait A., Allen M., Alpers C.E. Neovascular expression of E-selectin, intercellular adhesion molecule-1, and vascular adhesion molecule-1 in human atherosclerosis and their relation to intimal leukocyte content. Circulation. 93:1996;672-682.
29. de Boer OJ, van der Wal AC, Becker AE. Expression of adhesion molecules on neovessels in atherosclerotic plaques. Differences between lipid-rich and fibrous plaques. J Am Coll Cardiol 1998;31:420. (Abstract).
30. Kovanen P.T., Kaartinen M., Paavonen T. Infiltrates of activated mast cells at the site of coronary atheromatous erosion or rupture in myocardial infarction. Circulation. 92:1995;1084-1088.
31. Carr S.C., Farb A., Pearce W.H., Virmani R., Yao J.S.T. Activated inflammatory cells are associated with plaque rupture in carotid artery stenosis. Surgery. 122:1997;757-764.
32. Farb A., Burke A.P., Tang A.L.et al. Coronary plaque erosion without rupture into a lipid core: a frequent cause of coronary thrombosis in sudden coronary death. Circulation. 93:1996;1354-1363.
33. Moreno P.R., Falk E., Palacios I.F.et al. Macrophage infiltration in acute coronary syndromes: implications for plaque rupture. Circulation. 90:1994;775-778.
34. Brown D., Hibbs M., Keaney M., Isner J. Identification of 92 Kd gelatinase in human coronary atherosclerotic lesions; association of active enzyme synthesis with unstable angina. Circulation. 91:1995;2125-2131.
35. Kaartinen M., van der Wal A.C., Piek J.J.et al. Mast cell infiltration in acute coronary syndromes: implications for plaque rupture. J Am Coll Cardiol. 32:1998;606-612.
36. Haberbosch W., Bohle R.M., Franke F.E.et al. The expression of angiotensin-1 converting enzyme in human atherosclerotic plaques is not related to the deletion/inserton polymorphism but to the risk of restenosis after coronary interventions. Atherosclerosis. 130:1997;203-213.
37. Zeiher A., Gobel H., Ihling C. Tissue endothelin-1 immunoreactivity in the active coronary atherosclerotic plaque. A clue to the mechanism of increased vasoreactivity of the culprit lesion in unstable angina. Circulation. 91:1995;941-947.
38. Annex B.H., Denning S.M., Keith M.C. Differential expression of tissue factor protein in directional atherectomy specimens from patients with stable and unstable coronary syndromes. Circulation. 91:1995;614-622.
39. Moreno P.R., Bernardi V.H., Lopez-Cuellar J.et al. Macrophages, smooth muscle cells, and tissue factorin unstable angina. Implications for cell mediated thrombogenicity in acute coronary syndromes. Circulation. 94:1996;3090-3097.
40. van der Wal A.C., Piek J.J., de Boer O.J.et al. Recent onset activation of the plaque immune response in coronary lesions underlying acute coronary syndromes. Heart. 80:1998;14-18.
41. Escaned J., van Suylen R.J., MacLeod D.et al. Histological characteristics of tissue excised during directional coronary atherectomy in stable and unstable angina pectoris. Am J Cardiol. 71:1993;1442-1447.
42. Flugelman M.Y., Virmani R., Corren R.et al. Smooth muscle cell abundance and fibroblast growth factors in coronary lesions of patients with non fatal unstable angina: a clue to the mechanism of transformation from the stable to the unstable clinical state. Circulation. 88:1993;2493-2500.
43. Falk E., Fuster V. Angina pectoris and disease progression. Circulation. 92:1995;2033-2035.
44. Kaski J.C., Chester M.R., Chen L., Katrirsis D. Rapid angiographic progression of coronary artery disease in patients with angina pectoris. The role of complex stenosis morphology. Circulation. 92:1995;2058-2065.
45. Hansson G.K. Immune and inflammatory mechanisms in the development of atherosclerosis. Br Heart J. 69(suppl):1993;S38-S41.
46. van der Wal A.C., Koch K.T., Piek J.J., de Boer O.J., Becker A.E. Inflammation in atherosclerotic plaques: a clinically crucial event. Fibrinolysis and Proteolysis. 11(suppl 1):1997;125-128.
47. Libby P. Molecular bases of acute coronary syndromes. Circulation. 91:1995;2844-2850.
48. Campbell G.R., Campbell J.H., Manderson J.A., Horrigan S., Rennick E. Arterial smooth muscle: a multifunctional mesenchymal cell. Arch Pathol Lab Med. 112:1988;977-986.
49. Amento E.P., Ehsani N., Palmer H., Libby P. Cytokines and growth factors positively and negatively regulate interstitial collagen gene expression in human vascular smooth muscle cells. Arterioscler Thromb. 11:1991;1223-1230.
50. Nikol S., Isner J.M., Pickering J.G.et al. Transforming growth factor B is increased in human vascular restenosis lesons. J Clin Invest. 90:1992;1582-1589.
51. Newby A.C. Molecular and cell biology of native coronary and vein graft atherosclerosis: regulation of plaque stability and vessel remodelling by growth factors and cell-extracellular matrix interactions. Coron Artery Dis. 8:1997;213-224.
52. Bjorkerud S., Bjorkerud B. Apoptosis is abundant in human atherosclerotic lesions, especially in inflammatory cells (macrophages and T cells), and may contribute to the accumulation of gruel and plaque instability. Am J Pathol. 149:1996;367-380.
53. Geng Y., Libby P. Evidence for apoptosis in advanced human atheroma: co-localization with interleukin-beta converting enzyme. Am J Pathol. 147:1995;251-266.
54. Isner J.M., Kearney M., Bortman S., Passeri J. Apoptosis in human atherosclerosis and restenosis. Circulation. 91:1995;2703-2711.
55. Henney A., Wakeley P., Davies M.J.et al. Localization of stromelysin gene expression in atherosclerotic plaques by in situ hybridization. Proc Natl Acad Sci USA. 88:1991;8154-8158.
56. Galis Z.S., Sukhova G.K., Lark M.W., Libby P. Increased expression of matrix metalloproteinases and matrix degrading activities in vulnerable regions of human atherosclerotic plaques. J Clin Invest. 94:1994;2493-2503.
57. Dollery C.M., McEwan J.R., Henney A.M. Matrix metalloproteinases and cardiovascular disease. Circ Res. 77:1995;863-868.
58. Galis Z.S., Sukhova G.K., Kranzhofer R., Clark S., Libby P. Macrophage foam cells from experimental atheroma constitutively produce matrix degrading proteinases. Proc Natl Acad Sci USA. 92:1995;402-406.
59. Mitchinson M.J., Ball R.Y., Carpenter K.L.H., Enright J.H. Macrophages and ceroid in human atherosclerosis. Eur Heart J. 11(suppl E):1990;116-121.
60. Pearson A.M. Scavenger receptors in innate immunity. Curr Opin Immunol. 8:1996;20-28.
61. Hansson G.K. Cell mediated immunity in atherosclerosis. Curr Opin Lipidol. 8:1997;301-311.
62. Frostegard J., Wu R., Giscombe R., Holm G., Lefvert A.K., Nilsson J. Induction of T cell activation by oxidized low density lipoprotein. Arterioscler Thromb. 12:1992;461-467.
63. Stemme S., Faber S., Holm J.et al. T lymphocytes from human atherosclerotic plaques recognize oxidized low density lipoprotein. Proc Natl Acad Sci USA. 92:1995;3893-3897.
64. + T cells infiltratre lesions of apolipoprotein-E-deficient mice. Am J Pathol. 149:1996;359-366.
65. Falk E. Advanced lesions and acute coronary syndromes: a pathologist's view. In: Fuster V, editor. Syndromes of atherosclerosis. Armonk, NY: Futura Publishing Company, Inc, 1996, pp. 81-104.
66. Koenig W. Haemostatic risk factors for cardiovascular diseases. Eur Heart J. 19(suppl C):1998;C39-C43.
67. Davies M.J., Woolf N., Rowles P.M., Pepper J. Morphology of the endothelium over atherosclerotic plaques in human coronary arteries. Br Heart J. 60:1988;459-465.
68. Davies M.J., Bland J., Hangartner J., Angelini A., Thomas A. Factors influencing the presence or absence of acute thrombi insudden ischemic death. Eur Heart J. 10:1989;203-208.
69. Falk E. Plaque rupture with wevere preexisting stenosis precipitating coronary thrombosis: characteristics of coronary atherosclerotic plaques underlying fatal occlusive thrombi. Br Heart J. 50:1983;127-134.
70. Ambrose J.A., Tannenbaum M.A., Alexpoulos D.et al. Angiographic progression of coronary artery disease and the development of myocardial infarction. J Am Coll Cardiol. 12:1988;56-62.
71. Alderman E.L., Corley S.D., Fisher L.D.et al. Five year follow up factors associated with progression of coronary artery disease in the Coronary Artery Surgery Study. J Am Coll Cardiol. 22:1993;1141-1154.
72. Glagov S., Weisenberg E., Zarins C.K., Stanunavicius R., Kolettis G. Compensatory enlargment of human atherosclerotic coronary arteries. N Engl J Med. 316:1986;1371-1375.
73. Pasterkamp G., Wensing P.J.W., Post M.J.et al. Paradoxical arterial wall shrinkage may contribute to luminal narrowing of human atherosclerotic femoral arteries. Circulation. 91:1995;1444-1449.
74. Eefting F.D., Pasterkamp G., Clarijs R.J.A.G.M., van Leeuwen T.G., Borst C. Remodelling of the atherosclerotic arterial wall: a determinant of luminal narrowing in human coronary arteries. Coron Artery Dis. 8:1997;415-421.
75. Pasterkamp G., Schoneveld A.H., van der Wal A.C.et al. The relation of arterial geometry with luminal narrowing and histological markers for plaque vulnerability: the remodeling paradox. J Am Coll Cardiol. 32:1998;655-662.
76. Mitchinson M.J. Chronic periaortitis and periarteritis. Histopathology. 8:1984;589-600.
77. van der Wal A.C., Becker A.E., Das P.K. Medial thinning and atherosclerosis B evidence for a local inflammatory effect. Atherosclerosis. 103:1993;55-64.
78. Wissler R.W. An overview of the quantitative influence of several risk factors on progression of atherosclerosis in young people in the United States. Am J Med Sci. 310(suppl 1):1995;29-36.
79. Burke A.P., Farb A., Malcolm G.T.et al. Coronary risk factors and plaque morphology in men with coronary disease who died suddenly. N Engl J Med. 336:1997;1276-1282.
80. Wissler R.W. The PDAY Collaborating Investigators. New insights into the pathogenesis of atherosclerosis as revealed by PDAY. Atherosclerosis. 108(suppl):1994;S3-S20.
81. Zarins C.K., Giddens D.P., Glagov S. Carotid bifurcation atherosclerosis: Quantitative correlaton of plaque localization with flow velocity profiles and shear stress. Circ Res. 53:1983;502-514.
82. Sterpetti A.V., Cucina A., Fragale A.et al. Shear stress influences the release of platelet derived growth factor and basic fibroblast growth factor by arterial smooth muscle cells. Eur J Vasc Surg. 8:1994;138-142.
83. Gimbrone M.A. Jr., Cybulsky M.I., Kume N., Collins T., Resnick N. Vascular endothelium: An integrator of pathophysiological stimuli in atherogenesis. Ann NY Acad Sci. 748:1995;122-132.
84. Walpola P.L., Gotlieb A.I., Cybulsky M.I., Langille B.L. Expression of ICAM-1 and VCAM-1 and monocyte adherence in arteries exposed to altered shear stress (published erratum appears in Arterioscler Thromb Vasc Biol 1995;15:429). Arterioscler Thromb Vasc Biol. 15:1995;2-10.
85. Dirksen MT, van der Wal AC, van den Berg FM, van der Loos CM, Becker AE. The distribution of inflammatory cells in atherosclerotic plaques relates to the direction of flow. Circulation 1998 (in press).